 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval: t; O% @! I9 H" R$ N
0 Y5 S" Y: @3 F3 c n3 G
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.8 A6 Z$ i# k3 T" U, ]: }
" M% m' O c9 U+ o" [ U) n# R
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
4 _1 L+ a6 L2 G6 r! h: z' L
6 H& l; B% F/ U" R# E, k 4 r/ z! W! C6 u' ?8 r b4 y
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
. @1 f8 S A" f" M! q) c9 _7 J5 r/ p( K$ @( y
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
" l. S" X; L' {$ M2 ? W' c* }+ e# a8 N' O1 D/ F& U7 p: z
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
. c* v7 _, Y: v# n
# C- D W5 d# w0 z4 TIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.! r6 g+ P7 O8 j' h$ h8 b- A: I2 J9 w
. B+ Q6 D E1 Y8 f% Q* z+ p- [0 \It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
6 a0 B$ u" n0 F& d! ~( v# Q: l
8 z4 R( {4 W+ u8 G7 f"As a scientist, it's one of the highlights of my CAREER," Shan said.
8 S$ P. y4 E) L7 z& ~% y! ~) M* X2 g! P
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
- ~ x! v! }) y' L' e. d; S& y5 [2 ~+ \- D n; `& s
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
$ U9 j6 ~! ?& {( G) X/ B
# ?; w, c6 \6 q8 qGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
' R* ~/ M9 B+ P# B
: Z- c5 b" u2 |' r0 I( GThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
* _2 V1 f: f6 \! k) E y& X( Y) M
$ G8 ^4 _8 d! K* O& D3 j% Y6 S* vhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
2 M: L% \/ `* |# z3 x
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
